New lung cancer drug combination treats up to 25% of resistant cases

Scientists at Massachusetts General Hospital found that more than half of patients with two forms of treatment resistance saw their lung tumors shrink with a new pairing of targeted drugs.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news